Skip to content

PTHS PTHS Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Opko Health logo
Opko HealthOPK
$87.38M+13.1%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's convertible debt (non-current)?
PTHS (PTHS) reported convertible debt (non-current) of $23.28M in Q1 2026.
What does convertible debt (non-current) mean?
This represents the portion of long-term debt obligations that can be converted into equity shares of the company, with a maturity date extending beyond one year. It serves as a strategic financing tool for biotechnology firms to fund research and development while potentially minimizing immediate cash interest burdens. Investors track this metric to assess the company's long-term leverage, potential for future equity dilution, and overall capital structure stability.